Boutayeb Saber

Summary

Country: France

Publications

  1. ncbi [Targeted therapies in digestive oncology]
    S Boutayeb
    Service d Oncologie Medicale, institut national d oncologie, CHU Ibn Sina, Rabat, Maroc
    Pathol Biol (Paris) 60:264-8. 2012
  2. ncbi [Protein tyrosine kinase inhibitors in cancer therapy]
    S Boutayeb
    Service d Oncologie Medicale, institut national d oncologie, CHU Ibn Sina, Rabat, Maroc
    Pathol Biol (Paris) 60:229-33. 2012
  3. ncbi Bevacizumab based chemotherapy in first line treatment of HER2 negative metastatic breast cancer: results of a Moroccan observational institutional study
    Lamiaa Boulaamane
    Department of Medical Oncology, National Institute of Oncology, Rabat, Morocco
    BMC Res Notes 5:162. 2012
  4. ncbi Squamous cell carcinoma in situ arising in mature cystic teratoma of the ovary: a case report
    Fatima A Zakkouri
    Department of Medical Oncology, National Institute of Oncology, Rabat, Morocco
    J Ovarian Res 4:5. 2011
  5. ncbi Triple malignancy in a single patient including a cervical carcinoma, a basal cell carcinoma of the skin and a neuroendocrine carcinoma from an unknown primary site: A case report and review of the literature
    Mohamed Mesmoudi
    Department of Medical Oncology, National Institute of Oncology, Rabat, Morocco
    J Med Case Reports 5:462. 2011
  6. ncbi Primary nasopharyngeal Hodgkin's disease: case report and literature review
    Youssef Bensouda
    Department of Medical Oncology, National Institute of Oncology, Rabat, Morocco
    J Med Case Reports 4:116. 2010
  7. ncbi Estimation of the cost of treatment by chemotherapy for early breast cancer in Morocco
    Saber Boutayeb
    Department of Mathematics Faculty of Sciences, Boulevard Mohamed VI, BP 717 Oujda, Morocco
    Cost Eff Resour Alloc 8:16. 2010
  8. ncbi Primary osteosarcoma of the breast: case report
    Boutayeb Saber
    Department of Medical Oncology, National Institute of Oncology, Rabat, Morocco
    Cases J 1:80. 2008

Collaborators

  • Errihani Hassan
  • Saber Boutayeb
  • Hassan Errihani
  • S Boutayeb
  • Lamiaa Boulaamane
  • H Errihani
  • Mohamed Mesmoudi
  • Fatima A Zakkouri
  • Nabil Ismaili
  • Youssef Bensouda
  • W Boutayeb
  • F Z Zakkouri
  • H Mrabti
  • M Bachouchi
  • M Mesmoudi
  • A Boutayeb
  • Z Fadoulkhair
  • K Bakkraoui
  • Y Bensouda
  • M Aitelhaj
  • Rachid Aasab
  • Lamiae Gamra
  • Tarik Mahfoud
  • Mouna Rimani
  • Hind Mrabti
  • Meryem Glaoui
  • Saloua Ouaouch
  • Naoual Ahbeddou
  • Mehdi Tazi
  • Kawtar El Hassani
  • Brahim Khalil El Gueddari
  • Issam Lalya
  • Nourredine Benjaafar
  • Wiam Boutayeb
  • Essaadi Ismail
  • Abdesslam Boutayeb

Detail Information

Publications8

  1. ncbi [Targeted therapies in digestive oncology]
    S Boutayeb
    Service d Oncologie Medicale, institut national d oncologie, CHU Ibn Sina, Rabat, Maroc
    Pathol Biol (Paris) 60:264-8. 2012
    ..The oncologist should develop high abilities to use these therapies especially concerning the indications, response's biomarkers, toxicities and evaluation methods...
  2. ncbi [Protein tyrosine kinase inhibitors in cancer therapy]
    S Boutayeb
    Service d Oncologie Medicale, institut national d oncologie, CHU Ibn Sina, Rabat, Maroc
    Pathol Biol (Paris) 60:229-33. 2012
    ..Already, this drug-family provides a major therapeutic weapon against cancer...
  3. ncbi Bevacizumab based chemotherapy in first line treatment of HER2 negative metastatic breast cancer: results of a Moroccan observational institutional study
    Lamiaa Boulaamane
    Department of Medical Oncology, National Institute of Oncology, Rabat, Morocco
    BMC Res Notes 5:162. 2012
    ..In Morocco, we conducted an observational study to investigate clinical features, treatment and prognosis associated with Bevacizumab based chemotherapy in first line treatment of HER2 negative MBC...
  4. ncbi Squamous cell carcinoma in situ arising in mature cystic teratoma of the ovary: a case report
    Fatima A Zakkouri
    Department of Medical Oncology, National Institute of Oncology, Rabat, Morocco
    J Ovarian Res 4:5. 2011
    ..abstract:..
  5. ncbi Triple malignancy in a single patient including a cervical carcinoma, a basal cell carcinoma of the skin and a neuroendocrine carcinoma from an unknown primary site: A case report and review of the literature
    Mohamed Mesmoudi
    Department of Medical Oncology, National Institute of Oncology, Rabat, Morocco
    J Med Case Reports 5:462. 2011
    ..abstract:..
  6. ncbi Primary nasopharyngeal Hodgkin's disease: case report and literature review
    Youssef Bensouda
    Department of Medical Oncology, National Institute of Oncology, Rabat, Morocco
    J Med Case Reports 4:116. 2010
    ..Primary Hodgkin's disease of the nasopharynx is a rare and uncommon event. It has a relatively favorable prognosis and represents less than 1% of all documented cases of Hodgkin's disease...
  7. ncbi Estimation of the cost of treatment by chemotherapy for early breast cancer in Morocco
    Saber Boutayeb
    Department of Mathematics Faculty of Sciences, Boulevard Mohamed VI, BP 717 Oujda, Morocco
    Cost Eff Resour Alloc 8:16. 2010
    ..This study provides health decision-makers with a first estimate of costs and the opportunity to achieve the optimal use of available data to estimate the needs of antimitotics and trastuzumab in Morocco...
  8. ncbi Primary osteosarcoma of the breast: case report
    Boutayeb Saber
    Department of Medical Oncology, National Institute of Oncology, Rabat, Morocco
    Cases J 1:80. 2008
    ..In addition, the absence of a direct connection between the tumour and the underlying skeleton is mandatory for the diagnosis.We report a case of primary osteosarcoma of the breast occurring in young patient with fatal evolution...